Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) insider Francine Kaufman sold 62,627 shares of Senseonics stock in a transaction that occurred on Friday, June 4th. The stock was sold at an average price of $3.00, for a total value of $187,881.00. Following the sale, the insider now owns 1,099,588 shares in the company, valued at $3,298,764. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Shares of NYSEAMERICAN SENS opened at $3.62 on Friday. Senseonics Holdings, Inc. has a twelve month low of $0.35 and a twelve month high of $5.56. The company has a market cap of $1.55 billion, a P/E ratio of -2.97 and a beta of 0.41. The firm has a 50 day moving average price of $0.48.
Senseonics (NYSEAMERICAN:SENS) last issued its quarterly earnings results on Thursday, May 13th. The company reported ($0.68) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.05) by ($0.63). As a group, research analysts anticipate that Senseonics Holdings, Inc. will post -0.11 earnings per share for the current fiscal year.
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Delphi Management Partners VIII L.L.C. bought a new position in Senseonics during the 4th quarter worth $8,585,000. Masters Capital Management LLC grew its stake in Senseonics by 369.0% during the 1st quarter. Masters Capital Management LLC now owns 9,380,649 shares of the company’s stock worth $24,765,000 after buying an additional 7,380,649 shares during the last quarter. BlackRock Inc. grew its stake in Senseonics by 101.1% during the 1st quarter. BlackRock Inc. now owns 5,637,619 shares of the company’s stock worth $14,883,000 after buying an additional 2,834,433 shares during the last quarter. Geode Capital Management LLC grew its stake in Senseonics by 97.6% during the 1st quarter. Geode Capital Management LLC now owns 2,365,138 shares of the company’s stock worth $6,243,000 after buying an additional 1,168,266 shares during the last quarter. Finally, Parian Global Management LP bought a new position in Senseonics during the 4th quarter worth $1,744,000. Hedge funds and other institutional investors own 16.01% of the company’s stock.
Senseonics Company Profile
Senseonics Holdings, Inc, a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to 90 and 180 days.
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.